(Q34351333)

1 August 2017

1 reference

title

Heparan sulfate: anchor for viral intruders? (English)

1 reference

1 August 2017

Spillmann D

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

83

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

811-817

1 reference

Structure and biological interactions of heparin and heparan sulfate

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Regulated diversity of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Domain structure of heparan sulfates from bovine organs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Microbial adherence to and invasion through proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Role of glycans in Plasmodium falciparum infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Heparin-binding activity of feline herpesvirus type 1 glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Adaptation of equine herpesvirus 1 to unnatural host led to mutation of the gC resulting in increased susceptibility of the virus to heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Infectious laryngotracheitis virus, an alpha herpesvirus that does not interact with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Early interactions of human herpesvirus 6 with lymphoid cells: role of membrane protein components and glycosaminoglycans in virus binding

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

HIV-1 attachment: another look.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Human papillomavirus infection requires cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Cell-specific kinetics and efficiency of herpes simplex virus type 1 entry are determined by two distinct phases of attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Analysis of the steps involved in Dengue virus entry into host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Host cyclophilin A mediates HIV-1 attachment to target cells via heparans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

In vivo protein transduction: delivery of a biologically active protein into the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2801%2901290-1

7 January 2021

10.1016/S0300-9084(01)01290-1

Identifiers

DOI

1 reference

1 August 2017

1 reference